Relation of Patient Age and Mortality to Reported Contraindications to Early Beta-Blocker Use for Non–ST-Elevation Acute Coronary Syndrome
Nancy M. Allen LaPointe(Duke Medical Center), Eric D. Peterson, Deborah B. Diercks, Matthew T. Roe(Clinical Research Institute), Anita Y. Chen(University of Rochester Medicine), David J. Cohen(Baim Institute for Clinical Research), E. Magnus Ohman(Duke University), James W. Hoekstra(Wake Forest University), W. Brian Gibler(University of Cincinnati), Francis M. Fesmire(Agency for Healthcare Research and Quality)
Cited by 9
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
|Journal of the American College of Cardiology|2014|3.6k
Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis
|New England Journal of Medicine|2010|3k